icer tirzepatide is a New Medication for Diabetes and Weight Loss Tirzepatide approved for weight loss
Description
If lifestyle optimization hasn't shifted the scale and you've been on semaglutide for at least 12 weeks, discussing dose increase, medication switch, or dual-compound therapy is reasonable
Patients were randomized 3:1:3:1 to semaglutide, matched placebo, liraglutide, matched placebo, and the study enrolled patients at 19 sites in the US
They provide personalized 1-1 coaching to help their clients make lifestyle changes and meet realistic goals pertaining to weight management, nutrition and exercise
With access to compounded semaglutide now highly restricted, FDA-approved GLP-1 therapies remain the standard of care for most patients
Indicates urinary tract infection
